India's cancer burden: Why the govt's CL ruling is so important Firstpost Early last year, when the Union government allowed the production of Nexavar, a liver and kidney cancer drug, by an Indian company against the wishes of multinational pharma major Bayer, the prices of several indigenously made cancer drugs tumbled. NGOs welcome DoP's move to issue CL for 3 cancer drugs Trastuzumab ... |
